Invesco’s Alpine Immune Sciences Inc ALPN Stock Holding History

Invesco’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-272,627	Closed	-$10.8M	–	4015
2024 Q1	$10.8M	Buy	272,627 +30,851	+13%	+$910K	﹤0.01%	1775
2023 Q4	$4.61M	Buy	241,776 +24,640	+11%	+$342K	﹤0.01%	2284
2023 Q3	$2.49M	Buy	+217,136	New	+$2.67M	﹤0.01%	2519

Invesco's ALPN Position: Q2 2024 in Review

Invesco sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 272,627 shares — an estimated $10.8M sold.

Invesco first reported a position in ALPN in Q3 2023 and held it in 3 quarters. The position peaked at $10.8M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Invesco reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Invesco sold 272,627 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $10.8M.
Invesco first reported a position in Alpine Immune Sciences Inc in Q3 2023 and held it in 3 quarters.
Invesco's Alpine Immune Sciences Inc position peaked at $10.8M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.